γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer

Table 5

Comparison of predictive models for 1-year prediction.

	1-year; prediction	1-year prediction without; variables p53 and 𝛾-h2ax
JR (%)	87.1	72.3
No. of patients	74/85	62/85
Accuracy	93.3	85.4
No. of patients	69/74	53/62